25-hydroxy-Vitamin D total (rat) ELISA
- Regulatory Status
- RUO
- Kit size
- 12 x 8
- Method
- ELISA
- Incubation time
- 1 x 2 h, 1 x 30 min, 1 x 15 min
- Standard range
- 5.3 - 133.0 ng/ml
- Specimen / Volumes
- 50 µL Serum
- Substrate / isotope
- TMB 450 nm
Immunoenzymetric assay for the quantitative measurement of 25-hydroxyvitamin D2 and D3 (25OH-D2 and 25OH-D3) in rat serum.
Vitamin D is the generic term used to designate Vitamin D2 or ergocalciferol and Vitamin D3 or cholecalciferol.
In the liver mainly, Vitamin D3 is metabolised into 25-Hydroxyvitamin D3 (25OH D3) which is the main form of Vitamin D circulating in the body.
25OH D3 is a precursor for other Vitamin D metabolites and has also a limited activity by itself.
The most active derivative is 1,25-hydroxyvitamin D3, produced in the kidney (or placenta) by 1-hydroxylation of 25OH D3.
25OH Vitamin D stimulates the intestinal absorption of both calcium and phosphorus and also bone resorption and mineralisation. Rats have been used as experimental model to investigate the effect of 25OH Vitamin D supplements on fracture healing.
25OH Vitamin D might also be active in other tissues responsible for calcium transport (placenta, kidney, mammary gland …) and endocrine gland (parathyroid glands, beta cells…).
Vitamin D3 and Vitamin D2 are also available by ingestion through food or dietary supplementation.
As Vitamin D2 is metabolised in a similar way to Vitamin D3, both contribute to the overall Vitamin D status of an individual.
Studies on rats have been conducted to compare metabolism of oral Vitamin D2 and oral Vitamin D3.(6) and to define the effect of Vitamin D3 intake on calcium metabolism.
Influence of vitamin D deficiency during intra uterine and early life on blood pressure has been suited in a rat model. In studies on rat PTH (parathyroid hormone), 25OH vitamin D is measured in rat serum to determine its influence on PTH secretion.
Our Product Families
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).
This is who we are.
As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
Happy to help.
At Tecan, we are driven to improve people’s lives and health.